ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Goldman Sachs Downgrades ResMed (RMD) to Neutral
April 27, 2015 8:18 AM EDTGoldman Sachs downgraded ResMed (NYSE: RMD) from Buy to Neutral.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $65.70 yesterday.
... MoreResMed (RMD) Reports In-Line Q3 EPS
April 23, 2015 4:41 PM EDTResMed (NYSE: RMD) reported Q3 EPS of $0.65, in-line with the analyst estimate of $0.65. Revenue for the quarter came in at $422.5 million versus the consensus estimate of $425.76 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
... More